PNT Annual EBITDA
$126.92 M
+$172.50 M+378.42%
31 December 2022
Summary:
As of January 29, 2025, PNT annual earnings before interest, taxes, depreciation & amortization is $126.92 million, with the most recent change of +$172.50 million (+378.42%) on December 31, 2022. During the last 3 years, it has risen by +$140.20 million (+1055.72%).PNT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT Quarterly EBITDA
-$28.76 M
+$1.95 M+6.36%
30 September 2023
Summary:
As of January 29, 2025, PNT quarterly earnings before interest, taxes, depreciation & amortization is -$28.76 million, with the most recent change of +$1.95 million (+6.36%) on September 30, 2023. Over the past year, it has dropped by -$4.52 million (-18.66%).PNT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT TTM EBITDA
$110.37 M
-$4.52 M-3.94%
30 September 2023
Summary:
As of January 29, 2025, PNT TTM earnings before interest, taxes, depreciation & amortization is $110.37 million, with the most recent change of -$4.52 million (-3.94%) on September 30, 2023. Over the past year, it has increased by +$189.40 million (+239.66%).PNT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PNT EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +378.4% | -18.7% | +239.7% |
| 3 y3 years | +1055.7% | -844.7% | +1886.5% |
| 5 y5 years | +1055.7% | -817.8% | +3622.2% |
PNT EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -115.0% | -13.0% |
POINT Biopharma Global EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$28.76 M(-6.4%) | $110.37 M(-3.9%) |
| June 2023 | - | -$30.71 M(+40.1%) | $114.90 M(-5.1%) |
| Mar 2023 | - | -$21.93 M(-111.4%) | $121.08 M(-4.6%) |
| Dec 2022 | $126.92 M(-378.4%) | $191.78 M(-891.2%) | $126.92 M(-260.6%) |
| Sept 2022 | - | -$24.24 M(-1.2%) | -$79.03 M(+10.0%) |
| June 2022 | - | -$24.53 M(+52.5%) | -$71.82 M(+28.3%) |
| Mar 2022 | - | -$16.08 M(+13.5%) | -$55.96 M(+22.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$45.59 M(+243.3%) | -$14.17 M(-16.8%) | -$45.62 M(+23.3%) |
| Sept 2021 | - | -$17.03 M(+96.3%) | -$36.98 M(+60.8%) |
| June 2021 | - | -$8.68 M(+51.2%) | -$23.00 M(+31.8%) |
| Mar 2021 | - | -$5.74 M(+3.7%) | -$17.45 M(+49.0%) |
| Dec 2020 | -$13.28 M | -$5.53 M(+81.7%) | -$11.71 M(+89.6%) |
| Sept 2020 | - | -$3.04 M(-2.8%) | -$6.18 M(+97.2%) |
| June 2020 | - | -$3.13 M | -$3.13 M |
FAQ
- What is POINT Biopharma Global annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for POINT Biopharma Global?
- What is POINT Biopharma Global annual EBITDA year-on-year change?
- What is POINT Biopharma Global quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for POINT Biopharma Global?
- What is POINT Biopharma Global quarterly EBITDA year-on-year change?
- What is POINT Biopharma Global TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for POINT Biopharma Global?
- What is POINT Biopharma Global TTM EBITDA year-on-year change?
What is POINT Biopharma Global annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of PNT is $126.92 M
What is the all time high annual EBITDA for POINT Biopharma Global?
POINT Biopharma Global all-time high annual earnings before interest, taxes, depreciation & amortization is $126.92 M
What is POINT Biopharma Global annual EBITDA year-on-year change?
Over the past year, PNT annual earnings before interest, taxes, depreciation & amortization has changed by +$172.50 M (+378.42%)
What is POINT Biopharma Global quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of PNT is -$28.76 M
What is the all time high quarterly EBITDA for POINT Biopharma Global?
POINT Biopharma Global all-time high quarterly earnings before interest, taxes, depreciation & amortization is $191.78 M
What is POINT Biopharma Global quarterly EBITDA year-on-year change?
Over the past year, PNT quarterly earnings before interest, taxes, depreciation & amortization has changed by -$4.52 M (-18.66%)
What is POINT Biopharma Global TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of PNT is $110.37 M
What is the all time high TTM EBITDA for POINT Biopharma Global?
POINT Biopharma Global all-time high TTM earnings before interest, taxes, depreciation & amortization is $126.92 M
What is POINT Biopharma Global TTM EBITDA year-on-year change?
Over the past year, PNT TTM earnings before interest, taxes, depreciation & amortization has changed by +$189.40 M (+239.66%)